Skip to main content

Advertisement

SpringerLink
Log in

The Current State of Implantable Tibial Nerve Stimulation Therapy

  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Overactive bladder (OAB) is a prevalent condition affecting 23% of the population in the USA. There are several options for third-line therapies (intradetrusoronabotulinumtoxinA injections, sacral (S3) nerve stimulation, and posterior tibial nerve stimulation (PTNS)), each with its own strengths and weaknesses.

Recent Findings

Implantable tibial nerve stimulators (ITNS) are a new type of device based on PTNSprinciples; however, ITNS may carry several advantages over previous therapeutic modalities. Typically, ITNS is an office-based procedure obviating the need for general anesthesia or sedation. There is no need for frequent office visits or repeat procedures (as with intradetrusoronabotulinumtoxinA injections) once these devices are implanted.

Summary

ITNS stimulators have enabled a much more flexible system of administering and managing tibial nerve stimulation. Not only does ITNS offer convenience, but it offers the ability to manipulate the frequency, length, and strength of stimulation sessions. This review describes the current available devices, published clinical data, and ongoing clinical trials for future devices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Du C, Berg WT, Siegal AR, Huang Z, Nguyen A, Cheung A, et al. A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies? Neurourol Urodyn. 2021;40(1):391–6. New OAB patients follow-up and progress to third-line therapies faster and more frequently with the use of a CCP in an FPMRS-trained urologist practice. However, many OAB patients still fail to follow up and overall utilization of third-line therapies remains low. Future studies are warranted to identify factors to why overall OAB compliance remains low.

  2. Lightner DJ, Gomelsky A, Souter L, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. J Urol. 2019;202(3):558–63.

    Article  PubMed  Google Scholar 

  3. •• Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438–43. This pivotal multicenter, double-blind, randomized, sham controlled trial provides level I evidence that percutaneous tibial nerve stimulation therapy is safe and effective in treating overactive bladder symptoms. The compelling efficacy of percutaneous tibial nerve stimulation demonstrated in this trial is consistent with other recently published reports and supports the use of peripheral neuromodulation therapy for overactive bladder.

  4. Moossdorff-Steinhauser HFA, Berghmans B. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: A systematic review. Neurourol Urodyn. 2013;32(3):206–14.

  5. Gaziev G, Topazio L, Iacovelli V, Asimakopoulos A, Di Santo A, De Nunzio C, et al. Percutaneous tibial nerve stimulation (PTNS) efficacy in the treatment of lower urinary tract dysfunctions: a systematic review. BMC Urol. 2013;13(1):61.

    Article  PubMed  PubMed Central  Google Scholar 

  6. • Du C, Berg W, Siegal AR, Huang Z, Jeong R, Hwang K, et al. Real-world Compliance With Percutaneous Tibial Nerve Stimulation Maintenance Therapy in an American Population. Urology. 2021;153:119–23. Only 39.5% of patients continue to undergo maintenance PTNS therapy after 1 year. Future studies are required to understand and ameliorate factors for low compliance in PTNS maintenance therapy.

  7. MacDiarmid S, Staskin DR, Lucente V, Kaaki B, English S, Gilling P, et al. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019;201(5):967–72.

    Article  PubMed  Google Scholar 

  8. Gilling P, Meffan P, Kaaki B, MacDiarmid S, Lucente V, Clark M, et al. Twelve-month Durability of a Fully-implanted, Nickel-sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence: A Single-Arm, Prospective Study. Urology. 2021;157:71–8.

    Article  PubMed  Google Scholar 

  9. Rogers A, Bragg S, Ferrante K, Thenuwara C, Peterson DKL. Pivotal Study of Leadless Tibial Nerve Stimulation with eCoin® for Urgency Urinary Incontinence: An Open-Label. Single Arm Trial J Urol. 2021;206(2):399–408.

    PubMed  Google Scholar 

  10. Kaaki B, English S, Gilling P, Meffan P, Lucente V, MacDiarmid S, et al. Six-Month Outcomes of Reimplantation of a Coin-Sized Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome With Urgency Urinary Incontinence. Female Pelvic Med Reconstr Surg. 2022;28(5):287–92.

    Article  PubMed  PubMed Central  Google Scholar 

  11. van Breda HMK, Martens FMJ, Tromp J, Heesakkers JPFA. A New Implanted Posterior Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome: 3-Month Results of a Novel Therapy at a Single Center. J Urol. 2017;198(1):205–10.

    Article  PubMed  Google Scholar 

  12. Heesakkers JPFA, Digesu GA, van Breda J, Van Kerrebroeck P, Elneil S. A novel leadless, miniature implantable Tibial Nerve Neuromodulation System for the management of overactive bladder complaints. Neurourol Urodyn. 2018;37(3):1060–7.

    Article  PubMed  Google Scholar 

  13. Dorsthorst MJT, Digesu GA, Tailor V, Gore M, van Kerrebroeck PE, van Breda HMK, et al. 3-Year Followup of a New Implantable Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome. J Urol. 2020;204(3):545–50.

    Article  PubMed  Google Scholar 

  14. te Dorsthorst M, Digesu A, van Kerrebroeck P, Elneil S, van Breda J, Janssen D, et al. Patient-tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms. Neurourol Urodyn. 2022;41(2):679–84.

    Article  Google Scholar 

  15. Sirls LT, Schonhoff A, Waldvogel A, Peters KM. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder - Sirls - 2023 - Neurourology and Urodynamics - Wiley Online Library [Internet]. [cited 2023 Mar 26]. https://onlinelibrary.wiley.com/doi/10.1002/nau.25117?af=R

  16. Khaneshi M, Rahnama ’i Mohammad Sajjad, Ebrahimi SH. Mp32-17 effectivity of a novel implantable device (stimrouter) for the treatment of overactive bladder syndrome: 30 months results of a multi-centre study. J Urol. 2022;207(Supplement 5):e538.

    Article  Google Scholar 

  17. Keith Xavier, Dennis Miller, Kevin Benson, Kimberly Burgess, Janet Harris-Hicks, Robert Simon, et al. NM21 FEASIBILITY STUDY TO CHARACTERIZE THE IMPLANT PROCEDURE FOR A LEADLESS TIBIAL NERVE STIMULATOR, SUFU 2023 Conference. https://sufuorg.com/docs/meetings/sufu2303/abstracts.aspx. Accessed March 2023

  18. Moskowitz D, Adelstein SA, Lucioni A, Lee UJ, Kobashi KC. Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers-Are We Doing Enough? J Urol. 2018;199(3):779–84.

    Article  PubMed  Google Scholar 

Download references

Funding

This review did not receive any funding.

Author information

Authors and Affiliations

  1. Department of Urology, Stony Brook University, Stony Brook, USA

    Jacob Hartman-Kenzler & Jason Kim

  2. Stony Brook University School of Medicine, Stony Brook, USA

    Joseph Pizzuti

Authors
  1. Jacob Hartman-Kenzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Pizzuti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jacob Hartman-Kenzler.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

Jacob Hartman-Kenzler: No conflicts of interest

Joseph Pizzuti: No conflicts of interest

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hartman-Kenzler, J., Pizzuti, J. & Kim, J. The Current State of Implantable Tibial Nerve Stimulation Therapy. Curr Bladder Dysfunct Rep 18, 274–279 (2023). https://doi.org/10.1007/s11884-023-00711-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-023-00711-9

Keywords

Search

Navigation